SHMT2 and cancer: SIRT5 desuccinylates and activates SOD1 to eliminate ROS [30], desuccinylates and activates PKM2 to block macrophage IL-1β production and prevent DSS-induced colitis [31], and desuccinylates and activates SHMT2 to drive cancer cell proliferation [32].